Literature DB >> 6863512

Group VE-1 septicemia.

S A Berger, Y Siegman-Igra, J Stadler, A Campus.   

Abstract

A severely immunocompromised patient developed septicemia while under treatment for pancreatitis. An organism isolated from three separate blood cultures was identified as CDC group VE-1. The biochemical characteristics, taxonomy, and antibiotic sensitivity of this organism are presented.

Entities:  

Mesh：

Year:  1983        PMID： 6863512      PMCID： PMC272768          DOI： 10.1128/jcm.17.5.926-927.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  4 in total

1.  Characteristics of yellow-pigmented nonfermentative bacilli (groups VE-1 and VE-2) encountered in clinical bacteriology.

Authors:  G L Gilardi; S Hirschl; M Mandel
Journal:  J Clin Microbiol       Date:  1975-04       Impact factor: 5.948

2.  Group VE-2 (Chromobacterium typhiflavum) bacteremia.

Authors:  F D Pien
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

3.  Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility.

Authors:  M M Pedersen; E Marso; M J Pickett
Journal:  Am J Clin Pathol       Date:  1970-08       Impact factor: 2.493

4.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493
  4 in total
  8 in total

1.  Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.

Authors:  Benoît Doublet; Frédéric Robin; Isabelle Casin; Laëtitia Fabre; Anne Le Fleche; Richard Bonnet; François-Xavier Weill
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

2.  Pseudomonas species Ve-2 septicemia.

Authors:  J L Gómez Garcés; J M Aguado; M A Fernández-Clúa; F Soriano
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

3.  Prosthetic valve endocarditis caused by group Ve-1 bacteria (Chromobacterium typhiflavum).

Authors:  T O'Leary; I W Fong
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

4.  Prosthetic valve endocarditis caused by Pseudomonas luteola.

Authors:  Jean-Paul Casalta; Pierre-Edouard Fournier; Gilbert Habib; Alberto Riberi; Didier Raoult
Journal:  BMC Infect Dis       Date:  2005-10-12       Impact factor: 3.090

5.  Chryseomonas luteola identified as the source of serious infections in a Moroccan University Hospital.

Authors:  Wafae Chihab; Ahmed S Alaoui; Mohamed Amar
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

6.  Recurrent Pseudomonas luteola (CDC group Ve-1) peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis.

Authors:  B J Connor; R T Kopecky; P A Frymoyer; B A Forbes
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

7.  Bacteremia caused by CDC group Ve-1 in previously healthy patient with granulomatous hepatitis.

Authors:  J M Engel; F S Alexander; C T Pachucki
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

8.  Postoperative infant septicemia caused by Pseudomonas luteola (CDC group Ve-1) and Pseudomonas oryzihabitans (CDC group Ve-2).

Authors:  J Freney; W Hansen; J Etienne; F Vandenesch; J Fleurette
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.